Caitong International Asset Management Co., LTD Royalty Pharma PLC Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 6,829 shares of RPRX stock, worth $226,176. This represents 0.16% of its overall portfolio holdings.
Number of Shares
6,829Holding current value
$226,176% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
481Shares Held
283MCall Options Held
2.05MPut Options Held
373K-
Morgan Stanley New York, NY41MShares$1.36 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$762 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$444 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$403 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.5B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...